Trevor Pugh

Researcher
  • Princess Margaret Cancer Centre
  • University Health Network
  • University of Toronto
Home > About Us > Our People > Researcher Bio
  • Bio

Related Research

  • Pediatric & Young Adult Cancers

    Early detection and prevention of cancer in Li-Fraumeni Syndrome

    A team of Toronto- and Halifax-based scientists has received renewed funding from the Terry Fox Research Institute to continue its groundbreaking research into Li-Fraumeni Syndrome (LFS)—a rare ...

    Read More
  • Ovarian Cancer

    Immunotherapy network (iTNT): targeting ovarian cancer

    Both around the world and in Canada, teams of researchers are working hard to harness the power of a patient’s own immune system to eradicate cancer through immunotherapy. Hailed now as the four...

    Read More
  • Completed
    Pediatric & Young Adult Cancers

    Single cell dissection and non-invasive monitoring of childhood cancer and immune systems during treatment

    How do different pediatric tumours respond to immunotherapy? That’s the primary question a newly funded TFRI investigator seeks to answer. Using immunotherapy to destroy cancer cells is an exci...

    Read More
  • Completed
    Breast Cancer

    New era of precision medicine in triple-negative breast cancer

    Triple-negative breast cancer (TNBC) persists as a deadly form of breast cancer today that lacks effective therapies. Now, a newly formed and funded Terry Fox Research Institute team hopes to employ a...

    Read More
  • Completed
    Multiple Cancers

    BC Cancer-Princess Margaret Pilot for the Marathon of Hope Cancer Centres

    In February of 2017, the Terry Fox Research Institute and two leading cancer centres in Canada – the Princess Margaret Cancer Centre in Toronto and BC Cancer in Vancouver –&...

    Read More

Related News & Events

  • Research Highlight|May 09, 2023

    Scientists find Li-Fraumeni syndrome defined by more than one gene; expansion of genetic and epigenetic testing will benefit patients

    Scientists at The Hospital for Sick Children in Toronto find Li-Fraumeni syndrome may be defined by more than one gene, highlighting the benefits of e...

  • Research Highlight|February 10, 2022

    Gut bacteria linked to immune suppression in pancreatic cancer: Study

    Lactobacillus – a type of bacteria thought to promote gut health – can alter the function of immune cells called macrophages in the pancreatic tumour ...

  • Research Highlight|September 10, 2021

    New study helps understand who will benefit from immunotherapy

    TFRI-funded researchers at the Princess Margaret Cancer Centre in Toronto have made findings which help expand understanding of which patients will be...

  • Research Highlight|January 08, 2021

    Cancer cells hibernate like bears to evade harsh chemotherapy

    A team led by Dr. Catherine O’Brien, a TFRI-funded scientist at the Princess Margaret Cancer Centre in Toronto, discovered that when under threat, all...

  • Research Highlight|August 31, 2020

    Repurposing cholesterol drugs to treat multiple myeloma

    A new study TFRI-funded researchers at Princess Margaret Cancer Centre found that drugs prescribed to lower blood cholesterol, known as statins, may b...

  • TFRI News|August 17, 2020

    Marathon of Hope Cancer Centres Network operational plan continues to take shape

    Plans for implementation of the new pan-Canadian network to accelerate precision medicine continue to move ahead with partners and leaders from the fo...

  • Research Highlight|August 04, 2020

    A blood test could predict who benefits from immunotherapy

    A test which detects changing levels of tumour fragments in the blood may be an easy, non-invasive and quick way to predict who will benefit from immu...

  • Research Highlight|January 15, 2019

    Study reveals genomic differences between long- and short- term survivors of high-grade serous ovarian cancer, advancing potential for individualized treatments

    Researchers may be one step closer to personalizing treatments for patients with high-grade serous ovarian cancer thanks to a new study that revealed ...

  • Research Highlight|July 01, 2017

    Collaborative generation, sharing and analysis of data could make precision medicine available for patients with colorectal cancer

    The TF4CN is allowing scientists in two of Canada’s biggest cancer research centres to work together like never before to tackle four distinct project...

  • All News & Events